|
π
|
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.
27 auth.
D. Felson,
D. Felson,
Jennifer J. Anderson,
Jennifer J. Anderson,
M. Boers,
C. Bombardier,
C. Bombardier,
D. Furst,
D. Furst,
C. Goldsmith,
C. Goldsmith,
Linda M. Katz,
Linda M. Katz,
R. Lightfoot,
R. Lightfoot,
...
H. Paulus,
H. Paulus,
V. Strand,
V. Strand,
P. Tugwell,
P. Tugwell,
M. Weinblatt,
M. Weinblatt,
H. Williams,
H. Williams,
F. Wolfe,
S. Kieszak
|
11 |
1995 |
11
π
|
|
π
|
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.
27 auth.
D. Felson,
D. Felson,
Jennifer J. Anderson,
Jennifer J. Anderson,
M. Boers,
C. Bombardier,
C. Bombardier,
D. Furst,
D. Furst,
C. Goldsmith,
C. Goldsmith,
Linda M. Katz,
Linda M. Katz,
R. Lightfoot,
R. Lightfoot,
...
H. Paulus,
H. Paulus,
V. Strand,
V. Strand,
P. Tugwell,
P. Tugwell,
M. Weinblatt,
M. Weinblatt,
H. Williams,
H. Williams,
F. Wolfe,
S. Kieszak
|
11 |
1995 |
11
π
|
|
π
|
Rheumatoid arthritis
11 auth.
J. Smolen,
D. Aletaha,
A. Barton,
G. Burmester,
P. Emery,
G. Firestein,
...
A. Kavanaugh,
I. McInnes,
D. Solomon,
V. Strand,
Kazuhiko Yamamoto
|
10 |
2018 |
10
π
|
|
π
|
UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
50 auth.
D. Felson,
J. Smolen,
G. Wells,
Bin Zhang,
Lilian H D van,
Tuyl,
Julia Funovits,
D. Aletaha,
C. Allaart,
J. Bathon,
Stefano,
Bombardieri,
P. Brooks,
A. Brown,
M. Matucci-Cerinic,
...
Hyon K. Choi,
B. Combe,
M. Wit,
M. Dougados,
P. Emery,
D. Furst,
J. GΓ³mez-Reino,
G. Hawker,
E. Keystone,
D. Khanna,
John,
Kirwan,
T. Kvien,
R. LandewΓ©,
J. Listing,
K. Michaud,
E. MartΔ±Μn-Mola,
P. Montie,
T. Pincus,
P. Richards,
Jeffrey,
N. Siegel,
L. Simon,
T. Sokka,
V. Strand,
P. Tugwell,
Alan,
Tyndall,
D. Heijde,
S. Verstappen,
B. White,
Frederick,
Wolfe,
A. Zink,
M. Boers
|
9 |
2011 |
9
π
|
|
π
|
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
10 auth.
T. Pham,
D. Heijde,
R. Altman,
Jennifer J. Anderson,
N. Bellamy,
M. Hochberg,
...
L. Simon,
V. Strand,
T. Woodworth,
M. Dougados
|
9 |
2004 |
9
π
|
|
π¦
|
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
15 auth.
V. Strand,
S. Cohen,
Michael Schiff,
Arthur L. Weaver,
Roy Fleischmann,
Grant W. Cannon,
Robert Fox,
Larry W. Moreland,
Nancy J. Olsen,
Daniel Furst,
...
Jacques R. Caldwell,
J. Kaine,
John Sharp,
Frank Hurley,
I. Loew-Friedrich
|
9 |
1999 |
9
π¦
|
|
π
|
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.
10 auth.
N. Bellamy,
J. Kirwan,
M. Boers,
P. Brooks,
V. Strand,
P. Tugwell,
...
R. Altman,
K. Brandt,
M. Dougados,
M. Lequesne
|
9 |
1997 |
9
π
|
|
π
|
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
15 auth.
M. Boers,
J. Kirwan,
G. Wells,
D. Beaton,
L. Gossec,
M. DβAgostino,
P. Conaghan,
C. Bingham,
P. Brooks,
R. LandewΓ©,
...
L. March,
L. Simon,
J. Singh,
V. Strand,
P. Tugwell
|
9 |
2014 |
9
π
|
|
π
|
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
11 auth.
E. Keystone,
D. Heijde,
D. Mason,
R. LandewΓ©,
R. Vollenhoven,
B. Combe,
...
P. Emery,
V. Strand,
P. Mease,
C. Desai,
K. Pavelka
|
9 |
2008 |
9
π
|
|
π
|
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
8 auth.
D. Furst,
M. Schiff,
R. Fleischmann,
V. Strand,
C. Birbara,
D. Compagnone,
...
S. Fischkoff,
E. Chartash
|
9 |
2003 |
9
π
|
|
π¬
|
OMERACT: An international initiative to improve outcome measurement in rheumatology
P. Tugwell,
M. Boers,
P. Brooks,
L. Simon,
V. Strand,
L. Idzerda
|
9 |
2007 |
9
π¬
|
|
π
|
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
13 auth.
J. Smolen,
R. LandewΓ©,
P. Mease,
J. Brzezicki,
D. Mason,
K. Luijtens,
R. Vollenhoven,
A. Kavanaugh,
M. Schiff,
G. Burmester,
...
V. Strand,
J. VencovskΓ½,
D. Heijde
|
8 |
2008 |
8
π
|
|
π
|
Novel evidence-based systemic lupus erythematosus responder index.
12 auth.
R. Furie,
M. Petri,
Daniel J. Wallace,
E. Ginzler,
J. Merrill,
W. Stohl,
...
W. W. Chatham,
V. Strand,
A. Weinstein,
M. Chevrier,
Z. Zhong,
W. Freimuth
|
8 |
2009 |
8
π
|
